Ari Melnick

55.0k citations

355 papers · 23.9k indexed · 8 hit papers · h-index 84

Hematology top 0.1%
- Acute Myeloid Leukemia Research 82
Genetics top 0.1%
Cancer Research top 0.2%
Molecular Biology top 0.1%
- Epigenetics and DNA Methylation 111
- Cancer-related gene regulation 54
- Histone Deacetylase Inhibitors Research 38
- Protein Degradation and Inhibitors 36
Immunology top 0.5%
- Immune Cell Function and Interaction 51
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 63
Oncology
- CAR-T cell therapy research 40

Co-authors: Jonathan D. Licht María E. Figueroa Christopher E. Mason Francine E. Garrett-Bakelman José M. Polo Leandro Cerchietti Rita ShaknovichSheng Li
Cited by: Hematology Genetics Cancer Research
Journals: Blood (132 papers)Cancer Research (15 papers)Cell Reports (13 papers)
Partner nations: United States Canada Germany

In The Last Decade

Ari Melnick

339 papers receiving 23.6k citations

Hit Papers

8 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 Nature Medicine
2012 Genome biology
2012 Nature Genetics
2012 Cell
2012 Nature
2010 Nature Biotechnology
2010 Cancer Cell
1999 Blood

Peers

Countries citing papers authored by Ari Melnick

Since Specialization

Citations

This map shows the geographic impact of Ari Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Melnick more than expected).

Fields of papers citing papers by Ari Melnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ari Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Melnick. The network helps show where Ari Melnick may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ari Melnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ari Melnick Line = papers co-authored together Ari Melnick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	EZH2 INHIBITION ENHANCES CAR T ANTITUMOR EFFECT BY INDUCING LYMPHOMA IMMUNOGENICITY AND ENHANCING T CELL FUNCTION Hematological Oncology ·Yusuke Isshiki,Patrizia Porazzi,Ari Melnick,Marco Ruella,Wendy Béguelin	2023	0
2	Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival Blood Cancer Discovery ·Meng Li,Matthew Teater,Jun Young Hong,Noel R. Park,Cihangir Duy,Hao Shen,Ling Wang,Zhengming Chen,Leandro Cerchietti,Shawn M. Davidson,Hening Lin,Ari Melnick	2021	18
3	Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML Cancer Discovery ·Sheng Li,Darner Mora-Alvarado,Jiahui Wang,Cem Meydan,Jacob L. Glass,Alan H. Shih,Ruud Delwel,Ross L. Levine,Christopher E. Mason,Ari Melnick	2020	24
4	BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress Cancer Discovery ·Tharu M. Fernando,Rossella Marullo,Chalalai Klaipim,Jude M. Phillip,Shao Ning Yang,Daniëlle J. M. Ammerlaan,Ingrid Torregroza,Haelee Ahn,Todd Evans,Balázs Győrffy,Gilbert G. Privé,Masayuki Hirano,Ari Melnick,Leandro Cerchietti	2019	31
5	Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia Cancer Discovery ·Alan H. Shih,Cem Meydan,Kaitlyn Shank,Francine E. Garrett-Bakelman,Patrick S. Ward,Andrew M. Intlekofer,Abbas Nazir,Eytan M. Stein,Kristina M. Knapp,Jacob L. Glass,Jeremy Travins,Roby Juahta Ketaren,Camelia Gliser,Christopher E. Mason,Katharine Yen,Craig B. Thompson,Ari Melnick,Ross L. Levine	2017	71
6	MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia Cancer Research ·Nakhle S. Saba,Deanna H. Wong,Hanxing Lin,M. Romero de la Osa,Patricia Lobelle‐Rich,Eman L. Dadashian,Delong Liu,Lorena Fontán,Erik K. Flemington,Cydney Nichols,Chingiz Underbayev,Hana Safah,Ari Melnick,Adrian Wiestner,Sarah E. M. Herman	2017	40
7	SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents Cancer Research ·Warren Fiskus,Veena Coothankandaswamy,Jianguang Chen,Hongwei Ma,Kyungsoo Ha,Dyana T. Saenz,Stephanie Krieger,Christopher P. Mill,Baohua Sun,Peng Huang,Jeff S. Mumm,Ari Melnick,Kapil N. Bhalla	2016	57
8	DNMT3A Haploinsufficiency Transforms FLT3 ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia Cancer Discovery ·Sara E. Meyer,Tingting Qin,David E. Muench,Guilhem Velvé Casquillas,Meenakshi Venkatasubramanian,Vedano Gustine,Rosita Salamero-Lota,Steven D. Gore,Ruud Delwel,Elisabeth Paietta,Martin S. Tallman,Hugo F. Fernández,Ari Melnick,Michelle M. Le Beau,Scott C. Kogan,Nathan Salomonis,María E. Figueroa,H. Leighton Grimes	2016	70
9	A Virtual B Cell Lymphoma Model to Predict Effective Combination Therapy Blood ·Wei Du,Rebecca Goldstein,Yanwen Jiang,高森功,Leandro Cerchietti,Ari Melnick,Olivier Elemento	2014	1
10	Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia Cancer Research ·Warren Fiskus,Nakhle S. Saba,Min Shen,Mondana Ghias,Jinyun Liu,Soumyasri Das Gupta,Lata Chauhan,Rekha Rao,Sumedha Gunewardena,F. Ferrere,Christopher P. Austin,Kami J. Maddocks,John C. Byrd,Ari Melnick,Peng Huang,Adrian Wiestner,Kapil N. Bhalla	2014	198
11	Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies Blood ·Utthara Nayar,Pin Lü,Rebecca Goldstein,Jelena Vider,Gianna Ballon,Anna Rodina,Tony Taldone,Hediye Erdjument‐Bromage,مجید دانش,Ronald Blasberg,Ari Melnick,Leandro Cerchietti,Gabriela Chiosis,Y. Lynn Wang,Ethel Cesarman	2013	54
12	Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression Cancer Research ·Pei‐Chun Lin,Ya‐Lin Chiu,Samprit Banerjee,Kyung Park,Juan Miguel Mosquera,Ευγενία Γιαννοπούλου,Pedro Alves,Ashutosh Tewari,Mark Gerstein,Himisha Beltran,Ari Melnick,Olivier Elemento,Francesca Demichelis,Mark A. Rubin	2012	144
13	Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms Cancer Research ·Sangeeta Nischal,Sanchari Bhattacharyya,Maximilian Christopeit,Yiting Yu,Li Zhou,Tushar D. Bhagat,Davendra Sohal,Britta Will,Yongkai Mo,Masako Suzuki,Animesh Pardanani,Michael A. McDevitt,Jaroslaw P. Maciejewski,Ari Melnick,John M. Greally,Ulrich Steidl,Alison R. Moliterno,Amit Verma	2012	42
14	DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis Cancer Research ·Mrinal Y. Shah,Aparna Vasanthakumar,Natalie Y. Barnes,María E. Figueroa,Anna Kamp,Meta Ayuningtyas,Kelly R. Ostler,Elizabeth M. Davis,Lin Shang,John Anastasi,Michelle M. Le Beau,Ivan P. Moskowitz,Ari Melnick,Peter Pytel,Lucy A. Godley	2010	52
15	MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation Blood ·María E. Figueroa,Lucy Skrabanek,Yushan Li,Anchalee Jiemjit,Tamer E. Fandy,Elisabeth Paietta,Hugo F. Fernández,Martin S. Tallman,John M. Greally,Hetty E. Carraway,Jonathan D. Licht,Steven D. Gore,Ari Melnick	2009	231
16	Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma Journal of Clinical Oncology ·Peter Martin,Amy Chadburn,Paul J. Christos,陆恒炜,Richard R. Furman,Jia Ruan,Rebecca Elstrom,Rubén Niesvizky,Scott Ely,Maurizio DiLiberto,Ari Melnick,Daniel M. Knowles,Selina Chen‐Kiang,Morton Coleman,John P. Leonard	2009	234
17	Kaiso Contributes to DNA Methylation-Dependent Silencing of Tumor Suppressor Genes in Colon Cancer Cell Lines Cancer Research ·Eloisi Caldas Lopes,Ester Valls,María E. Figueroa,Alexander M. Mazur,Devayu Parikh,Gabriela Chiosis,Peter W. Laird,Nicole Schreiber‐Agus,John M. Greally,Egor Prokhortchouk,Ari Melnick	2008	86
18	Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas Cancer Research ·Leandro Cerchietti,José M. Polo,Gustavo Felippe da Silva,Pedro Farinha,Rita Shaknovich,Randy D. Gascoyne,Steven F. Dowdy,Ari Melnick	2008	25
19	Inhibition of DNA Methyltransferase Activates Tumor Necrosis Factor α–Induced Monocytic Differentiation in Acute Myeloid Leukemia Cells Cancer Research ·Anna Laurenzana,Luca A. Petruccelli,Filippa Pettersson,María E. Figueroa,Ari Melnick,Albert S. Baldwin,Francesco Paoletti,Wilson H. Miller	2008	24
20	BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms Blood ·Samir Parekh,José M. Polo,Rita Shaknovich,Przemysław Juszczyński,Paola R. Lev,Stella Maris Ranuncolo,Larisa Kimovna Dzubenko,Ulf Klein,Giorgio Cattoretti,Riccardo Dalla Favera,Margaret A. Shipp,Ari Melnick	2007	105

About Ari Melnick

Ari Melnick is a scholar working on Hematology, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 355 papers that have together received 23.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (111 papers), Acute Myeloid Leukemia Research (82 papers), Lymphoma Diagnosis and Treatment (63 papers), Cancer-related gene regulation (54 papers), Immune Cell Function and Interaction (51 papers), CAR-T cell therapy research (40 papers), Histone Deacetylase Inhibitors Research (38 papers) and Protein Degradation and Inhibitors (36 papers). The work is most often cited by research in Hematology (4.8k citations), Genetics (2.9k citations), Cancer Research (4.1k citations), Molecular Biology (16.7k citations) and Immunology (3.9k citations). Ari Melnick has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Jonathan D. Licht, María E. Figueroa, Christopher E. Mason, Francine E. Garrett-Bakelman, José M. Polo, Leandro Cerchietti, Rita Shaknovich, Sheng Li, Matthías Kormáksson and Katerina Hatzi. Their work appears in journals such as Blood, Cancer Research, Cell Reports, Cancer Cell and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact